Updated Jul 16, 2026
Goodrich Katherine has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $183K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 3.0K | $62.08 | $183K |
| 2026-06-16 | TARS | Tarsus Pharmaceuticals, Inc. | M — Option exercise | 3.0K | — | |
| 2026-01-15 | TARS | Tarsus Pharmaceuticals, Inc. | M — Option exercise | 2.2K | — |
Goodrich Katherine is a corporate insider — currently tracked as Director of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($183K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Goodrich Katherine profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.